
    
      This is a double blind randomized multicenter clinical trial, enrolling 100 consecutive
      patients undergoing elective Coronary Artery Bypass Graft Surgery (CABG). Patients randomly
      and within concealment method divided into two groups, one to receive oral pentoxifylline 400
      mg every 8 hours from three days before surgery and the other group received placebo. All the
      intubation , surgery and weaning protocols were the same.
    
  